Chimerix, Inc.
CMRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -34.6% | -99% | 1,609.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 98.7% | 76.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -45,506.1% | -28,695.7% | -178.2% | -4,565.1% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -41,692% | -25,338% | 509% | -12,925.5% |
| EPS Diluted | -0.99 | -0.93 | 1.94 | -3.01 |
| % Growth | -6.5% | -147.9% | 164.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |